secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cue Biopharma, Inc. (CUE)
CIK:        0001645460
Form:       8-K
Filed at:   2023-04-12T23:59:59+00:00
Accession:  0000950170-23-012492
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cue Biopharma appoints Patrick Verheyen to Board of Directors
-------------------------------------------------------------

- Patrick Verheyen appointed to the Board on April 11, 2023.
- Granted option to purchase 40,000 shares vesting over 3 years.
- Compensation per Director Compensation Policy filed as Exhibit 10.1.
- No reportable transactions or arrangements with any other person.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1645460/000095017023012492/0000950170-23-012492-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1645460/000095017023012492/cue-20230411.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-012492

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer